Cerus reported $-12364000 in Pre-Tax Profit for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Antares Pharma ATRS:US $ 7.22M 1.66M
Cerus CERS:US $ -12.36M 2.92M
Cytori Therapeutics CYTX:US $ -3.72M 0.92M
Meridian Bioscience VIVO:US $ 12.65M 0.18M
Neogen NEOG:US $ 12.93M 8.8M
Orasure Technologies OSUR:US $ -12.91M 15.16M
Quidel QDEL:US $ 296.59M 260.61M
Rockwell Medical RMTI:US $ -7.58M 0.82M
Sientra SIEN:US $ 28.5M 47.04M
Terumo 4543:JP Y 29262M 6758M